Levi Garraway, Roche CMO
Roche wins an edge in the hypercompetitive race for PD-(L)1 market share
Roche is looking to score a class win in the hypercompetitive PD-(L)1 field.
The pharma giant put out word Tuesday morning that their subcutaneous version …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
